Showing results (741-750 of 816) with videos related to

Sort By:
Pageof 82
Journal of the American Geriatrics Society|February 10, 2022
Clinical outcomes of monoclonal antibody therapy during a COVID-19 outbreak in a skilled nursing facility-Arizona, 2021Ariella P Dale, Matthew J Hudson, Darunee Armenta, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2000
Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcerH V Mao, B V Lak, T Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2019
Breaking tolerance with engineered class I antigen-presenting moleculesChristopher A Parks, Kalli R Henning, Kevin D Pavelko, et al.
MMWR. Morbidity and Mortality Weekly Report|November 21, 2014
Response to importation of a case of Ebola virus disease--Ohio, October 2014Carolyn L McCarty, Colin Basler, Mateusz Karwowski, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2007
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjectsNimalie D Stone, Shelia B Dunaway, Charles Flexner, et al.
JAMA Internal Medicine|May 20, 2017
A National Implementation Project to Prevent Catheter-Associated Urinary Tract Infection in Nursing Home ResidentsLona Mody, M Todd Greene, Jennifer Meddings, et al.
Spine Deformity|August 5, 2021
Modified Clavien-Dindo-sink classification system for adolescent idiopathic scoliosisNdéye F Guissé, Joseph D Stone, Lukas G Keil, et al.
Plos One|June 23, 2010
Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesionsEbbing P de Jong, Hongwei Xie, Getiria Onsongo, et al.
Cancer Research|October 28, 2025
ABBV-303 is a Natural Killer Cell Engager Specific for c-Met-Expressing TumorsJennifer D Stone, Kamonwan Fish, Devika Ashok, et al.
World Journal of Gastroenterology|May 20, 2017
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practiceShomron Ben-Horin, Jane M Andrews, Konstantinos H Katsanos, et al.
Pageof 82